Global Patent Index - EP 1750701 A1

EP 1750701 A1 20070214 - AMORPHOUS CLOPIDOGREL HYDROCHLORIDE AND ITS ANTITHROMBOTIC USE

Title (en)

AMORPHOUS CLOPIDOGREL HYDROCHLORIDE AND ITS ANTITHROMBOTIC USE

Title (de)

AMORPHES CLOPIDOGREL-HYDROCHLORID UND SEINE ANTITHROMBOTISCHE ANWENDUNG

Title (fr)

HYDROCHLORURE DE CLOPIDOGREL AMORPHE ET SON UTILISATION EN TANT QU'ANTITHROMBOTIQUE

Publication

EP 1750701 A1 20070214 (EN)

Application

EP 05756511 A 20050601

Priority

  • US 2005019326 W 20050601
  • GB 0412172 A 20040601
  • GB 0418395 A 20040818

Abstract (en)

[origin: WO2005117866A1] The invention provides methyl (+)-(S)-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetate hydrochloride in amorphous form, processes for the preparation of the amorphous form and a pharmaceutical composition containing the amorphous form. The amorphous form is useful as a blood platelet aggregation inhibitor and as an antithrombotic agent.

IPC 8 full level

A61K 31/4365 (2006.01); A61P 9/00 (2006.01); C07D 495/04 (2006.01)

CPC (source: EP)

A61P 9/00 (2018.01); C07D 495/04 (2013.01)

Citation (search report)

See references of WO 2005117866A1

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

DOCDB simple family (publication)

WO 2005117866 A1 20051215; EP 1750701 A1 20070214; IL 179717 D0 20070515

DOCDB simple family (application)

US 2005019326 W 20050601; EP 05756511 A 20050601; IL 17971706 A 20061130